当前位置:
X-MOL 学术
›
Am. J. Gastroenterol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch.
The American Journal of Gastroenterology ( IF 8.0 ) Pub Date : 2023-11-17 , DOI: 10.14309/ajg.0000000000002599 Maia Kayal 1 , Parakkal Deepak 2 , Poonam Beniwal-Patel 3 , Laura Raffals 4 , Marla Dubinsky 5 , Shannon Chang 6 , Peter D R Higgins 7 , Yue Jiang 8 , Raymond K Cross 9 , Millie D Long 10 , Hans H Herfarth 10 , Edward L Barnes 10
The American Journal of Gastroenterology ( IF 8.0 ) Pub Date : 2023-11-17 , DOI: 10.14309/ajg.0000000000002599 Maia Kayal 1 , Parakkal Deepak 2 , Poonam Beniwal-Patel 3 , Laura Raffals 4 , Marla Dubinsky 5 , Shannon Chang 6 , Peter D R Higgins 7 , Yue Jiang 8 , Raymond K Cross 9 , Millie D Long 10 , Hans H Herfarth 10 , Edward L Barnes 10
Affiliation
INTRODUCTION
There is a paucity of data on the real-world effectiveness of therapies in patients with Crohn's disease of the pouch.
METHODS
This was a prospective multicenter study evaluating the primary outcome of remission at 12 months of therapy for Crohn's disease of the pouch.
RESULTS
One hundred thirty-four patients were enrolled. Among the 77 patients with symptoms at baseline, 35 (46.7%) achieved remission at 12 months. Of them, 12 (34.3%) changed therapy. There was no significant association between therapy patterns and remission status.
DISCUSSION
Approximately 50% with symptoms at enrollment achieved clinical remission at 12 months, most of whom did so without a change in therapy.
中文翻译:
治疗的改变与袋性克罗恩病患者的缓解率增加无关。
引言 关于克罗恩氏袋病患者治疗的实际有效性的数据很少。方法 这是一项前瞻性多中心研究,评估了育儿袋克罗恩病治疗 12 个月后缓解的主要结果。结果 134 名患者入组。在 77 名基线时出现症状的患者中,35 名 (46.7%) 在 12 个月时获得缓解。其中 12 人(34.3%)改变了治疗方法。治疗模式和缓解状态之间没有显着关联。讨论 大约 50% 入组时出现症状的患者在 12 个月时获得临床缓解,其中大多数人在没有改变治疗的情况下实现了临床缓解。
更新日期:2023-11-17
中文翻译:
治疗的改变与袋性克罗恩病患者的缓解率增加无关。
引言 关于克罗恩氏袋病患者治疗的实际有效性的数据很少。方法 这是一项前瞻性多中心研究,评估了育儿袋克罗恩病治疗 12 个月后缓解的主要结果。结果 134 名患者入组。在 77 名基线时出现症状的患者中,35 名 (46.7%) 在 12 个月时获得缓解。其中 12 人(34.3%)改变了治疗方法。治疗模式和缓解状态之间没有显着关联。讨论 大约 50% 入组时出现症状的患者在 12 个月时获得临床缓解,其中大多数人在没有改变治疗的情况下实现了临床缓解。